These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33507971)

  • 1. Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota.
    Tanigawa T; Watanabe T; Higashimori A; Shimada S; Kitamura H; Kuzumoto T; Nadatani Y; Otani K; Fukunaga S; Hosomi S; Tanaka F; Kamata N; Nagami Y; Taira K; Shiba M; Suda W; Hattori M; Fujiwara Y
    PLoS One; 2021; 16(1):e0245995. PubMed ID: 33507971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5.
    Tanigawa T; Watanabe T; Otani K; Nadatani Y; Ohkawa F; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    Eur J Pharmacol; 2013 Mar; 704(1-3):64-9. PubMed ID: 23428631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide has the potential to reduce the intensity of NSAID-induced small intestinal injury: a double-blind, randomized, controlled trial evaluated by capsule endoscopy.
    Fujimori S; Takahashi Y; Gudis K; Seo T; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    J Gastroenterol; 2011 Jan; 46(1):57-64. PubMed ID: 20924615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota Plays a Key Role in Non-Steroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage.
    Otani K; Tanigawa T; Watanabe T; Shimada S; Nadatani Y; Nagami Y; Tanaka F; Kamata N; Yamagami H; Shiba M; Tominaga K; Fujiwara Y; Arakawa T
    Digestion; 2017; 95(1):22-28. PubMed ID: 28052268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity.
    Yamada S; Naito Y; Takagi T; Mizushima K; Horie R; Fukumoto K; Inoue K; Harusato A; Uchiyama K; Handa O; Yagi N; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1816-24. PubMed ID: 23020299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.
    Pozzoli C; Menozzi A; Grandi D; Solenghi E; Ossiprandi MC; Zullian C; Bertini S; Cavestro GM; Coruzzi G
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):283-91. PubMed ID: 17151854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells.
    Nagano Y; Matsui H; Muramatsu M; Shimokawa O; Shibahara T; Yanaka A; Nakahara A; Matsuzaki Y; Tanaka N; Nakamura Y
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S76-83. PubMed ID: 16184425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury.
    Kurokawa S; Katsuki S; Fujita T; Saitoh Y; Ohta H; Nishikawa K; Sato Y; Sato Y; Ohira K; Yamada M; Kato M
    J Gastroenterol; 2014 Feb; 49(2):239-44. PubMed ID: 23595613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.
    Lim YJ; Phan TM; Dial EJ; Graham DY; Lichtenberger LM
    Digestion; 2012; 86(2):171-7. PubMed ID: 22907267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebamipide attenuates nonsteroidal anti-inflammatory drugs (NSAID) induced lipid peroxidation by the manganese superoxide dismutase (MnSOD) overexpression in gastrointestinal epithelial cells.
    Nagano Y; Matsui H; Shimokawa O; Hirayama A; Tamura M; Nakamura Y; Kaneko T; Rai K; Indo HP; Majima HJ; Hyodo I
    J Physiol Pharmacol; 2012 Apr; 63(2):137-42. PubMed ID: 22653900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
    Niwa Y; Nakamura M; Ohmiya N; Maeda O; Ando T; Itoh A; Hirooka Y; Goto H
    J Gastroenterol; 2008; 43(4):270-6. PubMed ID: 18458842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of proton pump inhibitor or rebamipide use on gut microbiota of rheumatoid arthritis patients.
    Kim JW; Jeong Y; Park SJ; Jin H; Lee J; Ju JH; Ji GE; Park SH
    Rheumatology (Oxford); 2021 Feb; 60(2):708-716. PubMed ID: 32789440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
    Xu N; Zhang C; Jing L; Mou S; Cao X; Yu Z
    Int Immunopharmacol; 2021 Jan; 90():107136. PubMed ID: 33218942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.
    Hiratsuka T; Futagami S; Shindo T; Hamamoto T; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Shinoki K; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S84-9. PubMed ID: 16184426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of rebamipide against celecoxib-induced gastric mucosal cell apoptosis.
    Ishihara T; Tanaka K; Tashiro S; Yoshida K; Mizushima T
    Biochem Pharmacol; 2010 Jun; 79(11):1622-33. PubMed ID: 20132796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats.
    Mizoguchi H; Ogawa Y; Kanatsu K; Tanaka A; Kato S; Takeuchi K
    J Gastroenterol Hepatol; 2001 Oct; 16(10):1112-9. PubMed ID: 11686837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin-induced small bowel injuries and the preventive effect of rebamipide.
    Mizukami K; Murakami K; Abe T; Inoue K; Uchida M; Okimoto T; Kodama M; Fujioka T
    World J Gastroenterol; 2011 Dec; 17(46):5117-22. PubMed ID: 22171147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.
    Kim HJ; Kim JH; Moon W; Park J; Park SJ; Song GA; Han SH; Lee JH
    Biol Pharm Bull; 2015; 38(2):179-83. PubMed ID: 25747976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
    Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
    J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.